{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:31Z","timestamp":1792427671101,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093321","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:04:49Z","timestamp":1396040689000},"page":"e93321","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniel","family":"Abate-Daga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachimuthu","family":"Chinnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"ref1","volume":"4","unstructured":"Rosenberg SA (2012) Raising the Bar: The Curative Potential of Human Cancer Immunotherapy. Science Translational Medicine <volume>4<\/volume>.."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"NP Restifo","year":"2012","journal-title":"Nature Reviews Immunology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"RA Morgan","year":"2006","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens","volume":"26","author":"ME Dudley","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy","volume":"17","author":"SA Rosenberg","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"LA Johnson","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/mt.2010.272","article-title":"T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis","volume":"19","author":"MR Parkhurst","year":"2011","journal-title":"Molecular Therapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"JN Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"ref9","volume":"19","unstructured":"Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, <etal>et al<\/etal>.. (2013) Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nature Medicine <volume>19<\/volume>: : 747\u2013+."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/pros.20665","article-title":"Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor","volume":"67","author":"JA Dubovsky","year":"2007","journal-title":"Prostate"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1073\/pnas.0810777105","article-title":"Genome-wide analysis of cancer\/testis gene expression","volume":"105","author":"O Hofmann","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14712598.6.4.379","article-title":"Cancer testis antigens - their importance in immunotherapy and in the early detection of cancer","volume":"6","author":"A Suri","year":"2006","journal-title":"Expert Opinion on Biological Therapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"AJG Simpson","year":"2005","journal-title":"Nature Reviews Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1","volume":"29","author":"PF Robbins","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ng0894-502","article-title":"Identification of Novel Genes, Syt and Ssx, Involved in the T(X18)(P11.2q11.2) Translocation Found in Human Synovial Sarcoma","volume":"7","author":"J Clark","year":"1994","journal-title":"Nature Genetics"},{"key":"ref16","first-page":"5456","article-title":"Fusion of Syt to 2 Genes, Ssx1 and Ssx2, Encoding Proteins with Homology to the Kruppel-Associated Box in Human Synovial Sarcoma (Vol 14, Pg 2333, 1995)","volume":"14","author":"AJ Crew","year":"1995","journal-title":"Embo Journal"},{"key":"ref17","first-page":"4766","article-title":"The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40","volume":"56","author":"O Tureci","year":"1996","journal-title":"Cancer Research"},{"key":"ref18","first-page":"5601","article-title":"Tumor-reactive, SSX-2-specific CD8(+) T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients","volume":"63","author":"M Ayyoub","year":"2003","journal-title":"Cancer Research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","article-title":"Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions","volume":"180","author":"PF Robbins","year":"2008","journal-title":"Journal of Immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-08-1638","article-title":"Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691\u2013699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells","volume":"15","author":"MR Parkhurst","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311","volume":"36","author":"C Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00262-008-0562-x","article-title":"Recognition of NY-ESO-1+tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression","volume":"58","author":"JA Wargo","year":"2009","journal-title":"Cancer Immunology Immunotherapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1158\/0008-5472.CAN-06-1450","article-title":"Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR\/CD3 stability","volume":"66","author":"CJ Cohen","year":"2006","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/hum.2005.16.457","article-title":"Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions","volume":"16","author":"MS Hughes","year":"2005","journal-title":"Human Gene Therapy"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.174.7.4415","article-title":"Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tunior cell lines","volume":"174","author":"YB Zhao","year":"2005","journal-title":"Journal of Immunology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1089\/hum.1997.8.10-1189","article-title":"A simple and reliable method for screening retroviral producer clones without selectable markers","volume":"8","author":"M Onodera","year":"1997","journal-title":"Human Gene Therapy"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00262-008-0562-x","article-title":"Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression","volume":"58","author":"JA Wargo","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/gt.2008.90","article-title":"Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition","volume":"15","author":"S Yang","year":"2008","journal-title":"Gene Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2164-13-189","article-title":"Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2","volume":"13","author":"CB Garcia","year":"2012","journal-title":"BMC Genomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"249219","DOI":"10.1155\/2012\/249219","article-title":"Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy","volume":"2012","author":"J Przybyl","year":"2012","journal-title":"Sarcoma"},{"key":"ref31","volume":"9","unstructured":"Shiraishi T, Terada N, Zeng Y, Suyama T, Luo J, <etal>et al<\/etal>.. (2011) Cancer\/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. Journal of Translational Medicine <volume>9<\/volume>.."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1158\/0008-5472.CAN-11-2127","article-title":"Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer","volume":"71","author":"HA Smith","year":"2011","journal-title":"Cancer Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"D Atanackovic","year":"2007","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cji.0000175685.36239.e5","article-title":"SSX cancer testis antigens are expressed in most multiple myeloma patients - Co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs","volume":"28","author":"BJ Taylor","year":"2005","journal-title":"Journal of Immunotherapy"},{"key":"ref35","first-page":"1654","article-title":"Heterogeneous expression of the SSX cancer\/testis antigens in human melanoma lesions and cell lines","volume":"60","author":"NR dos Santos","year":"2000","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cji.0000175685.36239.e5","article-title":"SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs","volume":"28","author":"BJ Taylor","year":"2005","journal-title":"J Immunother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/1078-0432.CCR-08-0989","article-title":"Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma","volume":"15","author":"D Atanackovic","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/j.seminoncol.2013.04.015","article-title":"Chemotherapy and targeted therapies: are we making progress in castrate-resistant prostate cancer?","volume":"40","author":"J Hoffman-Censits","year":"2013","journal-title":"Semin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-8722-6-2","article-title":"Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"MA Kharfan-Dabaja","year":"2013","journal-title":"J Hematol Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.10634","article-title":"The SSX gene family: Characterization of 9 complete genes","volume":"101","author":"AO Gure","year":"2002","journal-title":"International Journal of Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.168.4.1717","article-title":"Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma","volume":"168","author":"M Ayyoub","year":"2002","journal-title":"Journal of Immunology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.174.3.1709","article-title":"Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma","volume":"174","author":"G Bricard","year":"2005","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"A Perez-Diez","year":"2007","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"A Corthay","year":"2005","journal-title":"Immunity"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.1001775","article-title":"A TCR Targeting the HLA-A*0201-Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer","volume":"186","author":"N Chinnasamy","year":"2011","journal-title":"Journal of Immunology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"RA Morgan","year":"2013","journal-title":"J Immunother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2011-02-337089","article-title":"Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety","volume":"118","author":"T Ochi","year":"2011","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.2700","article-title":"Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer","volume":"18","author":"E Provasi","year":"2012","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-10-1280","article-title":"Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials","volume":"16","author":"JL Davis","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"GP Linette","year":"2013","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/0008-5472.CAN-05-3020","article-title":"De novo induction of a cancer\/testis antigen by 5-aza-2&apos;-deoxycytidine augments adoptive immunotherapy in a murine tumor model","volume":"66","author":"ZS Guo","year":"2006","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:32:42Z","timestamp":1565299962000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093321"}},"subtitle":[],"editor":[{"given":"Nupur","family":"Gangopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093321","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}